FDA
-
-
-
-
-
-
-
Voyager Reports Third Quarter 2025 Financial and Operating Results
-
-
-
-
-
-
-
Voyager Therapeutics Reports First Quarter 2024 Financial and Operating Results
-
-
-
-
-
-
-
Neurocrine Bio (NBIX), Voyager (VYGR) Enter Pact for Development of Voyager's GBA1 Program and Other Next-Generation Gene Therapies for Neurological Diseases
-
-
-
-
-
-
-
Voyager Therapeutics Announces First Quarter 2021 Financial Results and Corporate Updates
-
-
-
-
-
-
-
Voyager Therapeutics Provides Update on NBIb-1817 (VY-AADC) Gene Therapy Program
-
-
-
-
-
-
-
Voyager Therapeutics (VYGR) Announces IND Submission for VY-HTT01 Program Was Placed on Clinical Hold
-
-
-
-
-
-
-
Voyager Therapeutics Reports First Quarter 2019 Financial Results and Corporate Highlights
-
322,084 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

